Nivolumab-induced interstitial lung disease in a patient with gastric cancer

We herein report a case of nivolumab-induced interstitial lung disease in a patient with gastric cancer. Nivolumab is a fully human IgG4 monoclonal antibody inhibitor of programmed death-1. A 69-year-old woman with metastatic gastric cancer being treated with nivolumab as fifth-line therapy develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Akie, Sakai, Daisuke, Kudo, Toshihiro, Nishida, Naohiro, Katou, Aya, Inagaki, Chiaki, Otsuru, Toru, Miyazaki, Yasuhiro, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Mori, Masaki, Doki, Yuichiro, Satoh, Taroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402314/
https://www.ncbi.nlm.nih.gov/pubmed/30863551
http://dx.doi.org/10.1093/omcr/omz007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402314/
https://www.ncbi.nlm.nih.gov/pubmed/30863551
http://dx.doi.org/10.1093/omcr/omz007

Ejemplares similares